Lupin informs about change in management

17 Jun 2024 Evaluate
Lupin has informed about the appointment of Abdelaziz Toumi as Chief Executive Officer, effective June 17, 2024, of Lupin Manufacturing Solutions (‘LMS’), newly formed subsidiary of the Company. LMS is engaged in the development, manufacture and sale of Active Pharmaceutical Ingredients and is starting to build its Contract Development and Manufacturing Operations (‘CDMO’) business. Disclosure in compliance with Regulation 30 read with Schedule III Part A Para A (7) of the Listing Regulations and SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, in respect of change in Senior Management is enclosed as Annexure - 'A’.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2147.55 -14.65 (-0.68%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.